Denali Therapeutics Inc (DNLI)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$16.92

Buy

$17.09

arrow-down$-0.0575 (-0.34%)

Prices updated at 17 Dec 2025, 14:30 EST

Prices minimum 15 mins delay

Prices in USD

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

NASDAQ

0.12%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$17.17 - $16.92
	$24.35 - $10.57
	-
	2,654.85m
	-
	-
	44,309
	2.87
	1,549,749.24
	1.76
	144.22m
	US24823R1059
	-2.92
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.